P21-Activated Kinase 4 Pak4 Maintains Embryonic Stem Cell Pluripotency via Akt Activation

Exploiting the pluripotent properties of embryonic stem cells (ESCs) holds great promise for regenerative medicine. Nevertheless, directing ESC differentiation into specialized cell lineages requires intricate control governed by both intrinsic and extrinsic factors along with the actions of specifi...

Full description

Saved in:
Bibliographic Details
Published in:Stem cells (Dayton, Ohio) Vol. 40; no. 10; p. 892
Main Authors: Cheng, Fangyuan, Li, Mingyue, Thorne, Rick Francis, Liu, Guangzhi, Zhang, Yuwei, Wu, Mian, Liu, Lianxin
Format: Journal Article
Language:English
Published: 21.10.2022
ISSN:1549-4918, 1549-4918
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Exploiting the pluripotent properties of embryonic stem cells (ESCs) holds great promise for regenerative medicine. Nevertheless, directing ESC differentiation into specialized cell lineages requires intricate control governed by both intrinsic and extrinsic factors along with the actions of specific signaling networks. Here, we reveal the involvement of the p21-activated kinase 4 (Pak4), a serine/threonine kinase, in sustaining murine ESC (mESC) pluripotency. Pak4 is highly expressed in R1 ESC cells compared with embryonic fibroblast cells and its expression is progressively decreased during differentiation. Manipulations using knockdown and overexpression demonstrated a positive relationship between Pak4 expression and the clonogenic potential of mESCs. Moreover, ectopic Pak4 expression increases reprogramming efficiency of Oct4-Klf4-Sox2-Myc-induced pluripotent stem cells (iPSCs) whereas Pak4-knockdown iPSCs were largely incapable of generating teratomas containing mesodermal, ectodermal and endodermal tissues, indicative of a failure in differentiation. We further establish that Pak4 expression in mESCs is transcriptionally driven by the core pluripotency factor Nanog which recognizes specific binding motifs in the Pak4 proximal promoter region. In turn, the increased levels of Pak4 in mESCs fundamentally act as an upstream activator of the Akt pathway. Pak4 directly binds to and phosphorylates Akt at Ser473 with the resulting Akt activation shown to attenuate downstream GSK3β signaling. Thus, our findings indicate that the Nanog-Pak4-Akt signaling axis is essential for maintaining mESC self-renewal potential with further importance shown during somatic cell reprogramming where Pak4 appears indispensable for multi-lineage specification.Exploiting the pluripotent properties of embryonic stem cells (ESCs) holds great promise for regenerative medicine. Nevertheless, directing ESC differentiation into specialized cell lineages requires intricate control governed by both intrinsic and extrinsic factors along with the actions of specific signaling networks. Here, we reveal the involvement of the p21-activated kinase 4 (Pak4), a serine/threonine kinase, in sustaining murine ESC (mESC) pluripotency. Pak4 is highly expressed in R1 ESC cells compared with embryonic fibroblast cells and its expression is progressively decreased during differentiation. Manipulations using knockdown and overexpression demonstrated a positive relationship between Pak4 expression and the clonogenic potential of mESCs. Moreover, ectopic Pak4 expression increases reprogramming efficiency of Oct4-Klf4-Sox2-Myc-induced pluripotent stem cells (iPSCs) whereas Pak4-knockdown iPSCs were largely incapable of generating teratomas containing mesodermal, ectodermal and endodermal tissues, indicative of a failure in differentiation. We further establish that Pak4 expression in mESCs is transcriptionally driven by the core pluripotency factor Nanog which recognizes specific binding motifs in the Pak4 proximal promoter region. In turn, the increased levels of Pak4 in mESCs fundamentally act as an upstream activator of the Akt pathway. Pak4 directly binds to and phosphorylates Akt at Ser473 with the resulting Akt activation shown to attenuate downstream GSK3β signaling. Thus, our findings indicate that the Nanog-Pak4-Akt signaling axis is essential for maintaining mESC self-renewal potential with further importance shown during somatic cell reprogramming where Pak4 appears indispensable for multi-lineage specification.
AbstractList Exploiting the pluripotent properties of embryonic stem cells (ESCs) holds great promise for regenerative medicine. Nevertheless, directing ESC differentiation into specialized cell lineages requires intricate control governed by both intrinsic and extrinsic factors along with the actions of specific signaling networks. Here, we reveal the involvement of the p21-activated kinase 4 (Pak4), a serine/threonine kinase, in sustaining murine ESC (mESC) pluripotency. Pak4 is highly expressed in R1 ESC cells compared with embryonic fibroblast cells and its expression is progressively decreased during differentiation. Manipulations using knockdown and overexpression demonstrated a positive relationship between Pak4 expression and the clonogenic potential of mESCs. Moreover, ectopic Pak4 expression increases reprogramming efficiency of Oct4-Klf4-Sox2-Myc-induced pluripotent stem cells (iPSCs) whereas Pak4-knockdown iPSCs were largely incapable of generating teratomas containing mesodermal, ectodermal and endodermal tissues, indicative of a failure in differentiation. We further establish that Pak4 expression in mESCs is transcriptionally driven by the core pluripotency factor Nanog which recognizes specific binding motifs in the Pak4 proximal promoter region. In turn, the increased levels of Pak4 in mESCs fundamentally act as an upstream activator of the Akt pathway. Pak4 directly binds to and phosphorylates Akt at Ser473 with the resulting Akt activation shown to attenuate downstream GSK3β signaling. Thus, our findings indicate that the Nanog-Pak4-Akt signaling axis is essential for maintaining mESC self-renewal potential with further importance shown during somatic cell reprogramming where Pak4 appears indispensable for multi-lineage specification.Exploiting the pluripotent properties of embryonic stem cells (ESCs) holds great promise for regenerative medicine. Nevertheless, directing ESC differentiation into specialized cell lineages requires intricate control governed by both intrinsic and extrinsic factors along with the actions of specific signaling networks. Here, we reveal the involvement of the p21-activated kinase 4 (Pak4), a serine/threonine kinase, in sustaining murine ESC (mESC) pluripotency. Pak4 is highly expressed in R1 ESC cells compared with embryonic fibroblast cells and its expression is progressively decreased during differentiation. Manipulations using knockdown and overexpression demonstrated a positive relationship between Pak4 expression and the clonogenic potential of mESCs. Moreover, ectopic Pak4 expression increases reprogramming efficiency of Oct4-Klf4-Sox2-Myc-induced pluripotent stem cells (iPSCs) whereas Pak4-knockdown iPSCs were largely incapable of generating teratomas containing mesodermal, ectodermal and endodermal tissues, indicative of a failure in differentiation. We further establish that Pak4 expression in mESCs is transcriptionally driven by the core pluripotency factor Nanog which recognizes specific binding motifs in the Pak4 proximal promoter region. In turn, the increased levels of Pak4 in mESCs fundamentally act as an upstream activator of the Akt pathway. Pak4 directly binds to and phosphorylates Akt at Ser473 with the resulting Akt activation shown to attenuate downstream GSK3β signaling. Thus, our findings indicate that the Nanog-Pak4-Akt signaling axis is essential for maintaining mESC self-renewal potential with further importance shown during somatic cell reprogramming where Pak4 appears indispensable for multi-lineage specification.
Author Thorne, Rick Francis
Liu, Lianxin
Zhang, Yuwei
Wu, Mian
Li, Mingyue
Cheng, Fangyuan
Liu, Guangzhi
Author_xml – sequence: 1
  givenname: Fangyuan
  surname: Cheng
  fullname: Cheng, Fangyuan
– sequence: 2
  givenname: Mingyue
  surname: Li
  fullname: Li, Mingyue
– sequence: 3
  givenname: Rick Francis
  surname: Thorne
  fullname: Thorne, Rick Francis
– sequence: 4
  givenname: Guangzhi
  surname: Liu
  fullname: Liu, Guangzhi
– sequence: 5
  givenname: Yuwei
  surname: Zhang
  fullname: Zhang, Yuwei
– sequence: 6
  givenname: Mian
  surname: Wu
  fullname: Wu, Mian
– sequence: 7
  givenname: Lianxin
  surname: Liu
  fullname: Liu, Lianxin
BookMark eNpNjj1PwzAURS1UJNrCyuyRJfT5I048RlGhiCIiAQNT5TivkmnilNqp6L8nEh0Yrs6djs6MTHzvkZBbBvcMtFiE2Nk2LMKPsZDCBZmyVOpEapZP_v0rMgvhC4DJNM-n5LPiLClsdEcTsaHPzpuAVNLK7CR9Mc7HcYEuu_pw6r2z9C1iR0tsW1q1w8Ht-4jenujRGVrsIj2rXO-vyeXWtAFvzpyTj4fle7lK1q-PT2WxTqxULCYiU2ghlzkKlakxkDNtBGsYKlEraxVvJKCV9VagBJ5aoZVA0DU0jCmT8jm5-_PuD_33gCFuOhfsGGg89kPYcKUVQMZ1yn8BH3dXmA
CitedBy_id crossref_primary_10_1038_s41417_024_00748_w
crossref_primary_10_1016_j_ebiom_2024_105162
ContentType Journal Article
Copyright The Author(s) 2022. Published by Oxford University Press.
Copyright_xml – notice: The Author(s) 2022. Published by Oxford University Press.
DBID 7X8
DOI 10.1093/stmcls/sxac050
DatabaseName MEDLINE - Academic
DatabaseTitle MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1549-4918
GroupedDBID ---
05W
0R~
123
18M
1OB
2WC
3WU
4.4
53G
5RE
5WD
7X8
8-0
8-1
AABZA
AACZT
AAESR
AAONW
AAPXW
AARHZ
AAUAY
AAVAP
AAZKR
ABCUV
ABDFA
ABEJV
ABGNP
ABHFT
ABJNI
ABLJU
ABMNT
ABNHQ
ABPTD
ABVGC
ABXVV
ABXZS
ACGFO
ACGFS
ACIWK
ACPOU
ACPRK
ACUFI
ACUTJ
ADBBV
ADGKP
ADIPN
ADKYN
ADQBN
ADVEK
ADXAS
ADZMN
AENEX
AFBPY
AFFZL
AFGWE
AFRAH
AFZJQ
AHGBF
AHMBA
AHMMS
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALXQX
AMYDB
ATGXG
AZBYB
AZVAB
BAWUL
BCRHZ
BEYMZ
BMXJE
BRXPI
CS3
DCZOG
DIK
DU5
E3Z
EMOBN
F5P
FD6
G-S
GX1
H13
HHY
HZ~
IH2
KOP
KSI
KSN
LATKE
LEEKS
LITHE
LMP
LOXES
LUTES
LYRES
MY~
N9A
NNB
NOMLY
NTU
O9-
OBOKY
OCZFY
OIG
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P2W
PQQKQ
RAO
ROX
SUPJJ
TEORI
TR2
WBKPD
WIN
WOHZO
WOQ
XV2
ZZTAW
~S-
ID FETCH-LOGICAL-c461t-376ec0848e3676918219a31d1e63b6cc62d40ec4bf3e4025c3963e09b0d116a52
IEDL.DBID 7X8
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000834287800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1549-4918
IngestDate Sun Sep 28 04:23:40 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c461t-376ec0848e3676918219a31d1e63b6cc62d40ec4bf3e4025c3963e09b0d116a52
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/stmcls/article-pdf/40/10/892/46589992/sxac050.pdf
PQID 2696007295
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2696007295
PublicationCentury 2000
PublicationDate 2022-10-21
PublicationDateYYYYMMDD 2022-10-21
PublicationDate_xml – month: 10
  year: 2022
  text: 2022-10-21
  day: 21
PublicationDecade 2020
PublicationTitle Stem cells (Dayton, Ohio)
PublicationYear 2022
SSID ssj0014588
Score 2.4183478
Snippet Exploiting the pluripotent properties of embryonic stem cells (ESCs) holds great promise for regenerative medicine. Nevertheless, directing ESC differentiation...
SourceID proquest
SourceType Aggregation Database
StartPage 892
Title P21-Activated Kinase 4 Pak4 Maintains Embryonic Stem Cell Pluripotency via Akt Activation
URI https://www.proquest.com/docview/2696007295
Volume 40
WOSCitedRecordID wos000834287800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7UKnjxLb5ZwevS7GbzOkkpFUEtBRXqqexONhBME23SYv-9s2lqD14Ej4EQlpmdb77M7nxDyA3-I2M4i4QJw0Mm8ZEp7XEWYOqJInCNDOpG4ceg3w-Hw2jQFNzK5lrlEhNroI4LsDXytvAjv5a59m4_PpmdGmVPV5sRGuuk5SKVsVe6guHqFMF2YdZ6qdJOUuPhj2ij2y6rMWRlu_xS4HjOLyCus8vd7n_XtUd2Gl5JO4uNsE_WTH5AthaTJueH5G0gOOtAPcvMxPQhzTF7UUmRQEr6pNLcVghK2hvrydyK5dLnyoxp12QZHWRTBJbCcus5naWKdt4r2nwKnXpEXu96L9171kxVYCB9XllEMWBV9I0Va0OrIGYpl8fc-K72AXwRS8eA1Ak6ChkRuBijxom0E3PuK08ck428yM0JoUg9NBLOMARM8iLQykRuEoaxhkQHCUSn5HppsxHuWnsUoXJTTMvRympnf3jnnGwL23WAKUPwC9JKMDLNJdmEWZWWk6va6d9_27Yk
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P21-Activated+Kinase+4+Pak4+Maintains+Embryonic+Stem+Cell+Pluripotency+via+Akt+Activation&rft.jtitle=Stem+cells+%28Dayton%2C+Ohio%29&rft.au=Cheng%2C+Fangyuan&rft.au=Li%2C+Mingyue&rft.au=Thorne%2C+Rick+Francis&rft.au=Liu%2C+Guangzhi&rft.date=2022-10-21&rft.issn=1549-4918&rft.eissn=1549-4918&rft.volume=40&rft.issue=10&rft.spage=892&rft_id=info:doi/10.1093%2Fstmcls%2Fsxac050&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1549-4918&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1549-4918&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1549-4918&client=summon